National indication document and aortic valve replacement landscape in the Netherlands.

ABSTRACT:

Introduction

Based on European guidelines, transcatheter aortic valve implementation (TAVI) could be the therapy of choice in patients with severe aortic stenosis aged ≥ 75 years. In the Netherlands, there has been a debate between healthcare providers and the National Health Care Institute regarding reimbursement for TAVI, which resulted in an indication document that defines TAVI patients who are eligible for reimbursement. This document has been effective since 1 January 2021.

Methods

We extracted data from the Netherlands Heart Registry for patients who underwent biological surgical aortic valve replacement (SAVR) or TAVI in the Netherlands from 2018 through 2021. We compared baseline characteristics and variables from the indication document for the subsequent years and

SUBMITTER: Eerdekens R 

PROVIDER: S-EPMC10667164 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature